| Hristo Shivarov, MD | |
|
12 Marks Rd, Ocean Springs, MS 39564 | |
| (228) 872-6329 | |
| Not Available |
| Full Name | Hristo Shivarov |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 18 Years |
| Location | 12 Marks Rd, Ocean Springs, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245639939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 26939 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ocean Springs Dialysis | Ocean springs, MS | Dialysis facility |
| Total Renal Care, Inc | Diberville, MS | Dialysis facility |
| Singing River Health System | Pascagoula, MS | Hospital |
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Mississippi, Llc | 0143580993 | 113 |
| Nephrology Associates Of Mobile, P.a. | 8729061668 | 35 |
News Archive
The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 3 days ago
| Entity Name | Kidney Disease & Hypertension Centers, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568491728 PECOS PAC ID: 5395811608 Enrollment ID: O20080911000167 |
News Archive
The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 3 days ago
| Entity Name | Ochsner Mississippi, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538674239 PECOS PAC ID: 0143580993 Enrollment ID: O20180216000366 |
News Archive
The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 3 days ago
| Entity Name | Nephrology Associates Of Mobile, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861477507 PECOS PAC ID: 8729061668 Enrollment ID: O20190725001692 |
News Archive
The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hristo Shivarov, MD 2712 Criswell Ave, Pascagoula, MS 39567-1143 Ph: (228) 762-0713 | Hristo Shivarov, MD 12 Marks Rd, Ocean Springs, MS 39564 Ph: (228) 872-6329 |
News Archive
The U.S. Department of Justice may intervene in a lawsuit against heart-device maker St. Jude Medical Inc. after allegations the company used medical studies to "pay kickbacks and boost product usage," The Wall Street Journal reports. "The U.S. Attorney's office in Boston launched an industry-wide probe nearly five years ago into whether makers of pacemakers and defibrillators were making improper payments to doctors.
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.
Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
› Verified 3 days ago
Dr. Nicole Roberts Walton, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3603 Bienville Blvd Ste 100, Ocean Springs, MS 39564 Phone: 228-872-8768 Fax: 228-872-9112 | |
Dr. Harry Bradley Heitzman, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1131 Ocean Springs Rd, Ocean Springs, MS 39564 Phone: 228-872-3191 Fax: 228-872-3676 | |
Subhas Sitaula, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2 Doctors Dr, Ocean Springs, MS 39564 Phone: 228-872-1951 | |
Dr. Shawn Keith French, DO Nephrology Medicare: May Accept Medicare Assignments Practice Location: 2113 Government St, Ocean Springs, MS 39564 Phone: 228-254-1366 Fax: 228-254-1367 | |
Rogin Subedi, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3704 Bienville Blvd Ste B, Ocean Springs, MS 39564 Phone: 228-872-4040 Fax: 228-872-3612 | |
Dr. Dipti Baral, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3635 Bienville Blvd, Ocean Springs, MS 39564 Phone: 228-872-1951 Fax: 228-875-9998 |